6
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Increased Concentrations of the NH2-Terminal Fragment of Gastrin-17 in Acute Duodenal Ulcer and Acute Gastritis

&
Pages 635-641 | Received 20 Aug 1982, Accepted 29 Oct 1982, Published online: 19 Feb 2010
 

Abstract

The concentration of the NH2-terminal fragment of gastrin-17 in serum was determined by radioimmunochemistry. Two antisera were used, one specific for the COOH-terminus and the other for the NH2-terminus of gastrin-17. The NH2-terminal gastrin-17 immunoreactivity in unfractionated serum correlated well with the amount of fragment found after gel filtration of the same sera (p < 0.001). In healthy subjects (no. = 100), the NH2- and COOH-terminal gastrin immunoreactivity was 8 ± 1 and 20 ± 1 pmol/l (mean ± SEM), respectively. In patients with acute duodenal ulcer (no. = 30) and acute gastritis (no. = 10) the NH2-terminal immunoreactivity was fourfold increased compared with in healthy subjects (p < 0.001), whereas the COOH-terminal was identical, the NH2- and COOH-terminal concentrations being 33 ± 7 and 22 ± 2 pmol/l in duodenal ulcer and 35 ± 6 and 21 ± 1 pmol/l in acute gastritis. Other groups of patients had NH2- and COOH-terminal gastrin concentrations in serum similar to those measured in healthy subjects. The results suggest that gastrin cells process gastrin-17 abnormally during the acute phase of duodenal ulcer and gastritis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.